1Jaakkola P,Mole DR,Tian YM,et al.Targeting of HIF-alpha to the yon Hippel-Lindau ubiquitylation complex by O-2-regulated prolyl hydroxylation[J].Science,2001,292:468-72.
2Talks KL,Turley H,Gatter KC,et al.Theexpression and distribution of the hypoxia inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues,cancers,tumor associated macrophages[J].Am J Pathol,2000,157:411-421.
3Zhong H,De Marzo A M,Laughner E,et al.Overexpression of hypoxia-inducible factor 1 alpha in common human cancer and their metastases[J].Cancer Res,1999,59 (22):5830-5835.
4Vleugel M M,Grei jer A E,Shvarts A,et al.Differential prognostic impact of hypoxia induced and diffuse HIF-1 alpha expression in invasive breast cancer[J].J Clin Pathol,2005,58(2):172-177.
5Fang J,Yan L,Shing Y,et al.HIF-1 alpha-mediated up-regulation of vascular endothelial growth factor,independent of basic fibroblast growth factor,is important in switch to the angiogenic phenotype during early twmorigenesis[J].Cancer Res,2001,61(15):5731 5735.
6Ryan HE,Poloni M,Mcnulty W,et al.Hypoxia-induclble factor 1 alpha is a positive factor in solid tumor growth[J].Cancer Res,2000,60:4010-4015.
84Sowter HN,Ratcliffe PJ,Watson P,et al.HIF-1-dependent regulation of hypoxia induction of the cell death factors BNIP3 and NIX in human tumors[J].Cancer Res,2001,61:6669-6671.
9Volm M,Koomagi R.Hypoxia-inducible factor (HIF-1)and its relationship to apoptosis and proliferation in lung cancer[J].Anticancer Res,2000,20(3A):1527-1533.
10Greijer,A E,Van der,E.The role of hypoxia inducible factor 1(HIF-1)in hypoxia induced apoptosis[J].J Clin Pathol,2004,57 (10):1009-1014.
二级参考文献14
1Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis- correlation in invasive breast carcinoma[J]. N Engl J Med. 1991.324(1): 1 -8.
2Kitamura K, Yamaguchi T, Taniguchi H, et al. Analysis of lymph node metastasis in early gastric cancer: rationale of imitated surgery [ J ]. J Surg Onclo, 1997,64 ( 1 ): 42 - 49.
3Kaipainen A, Korhoren J, Taipale J, et al. Expression of the fins-like tyrosine kinase FLT-4 gene becomes restricted to endothelium of lymphatic vessels during development[J] . Proc Natl Acad Sci USA, 1995, 92(8): 3566- 3570.
4Fisher ER. Detection and significance of occult axillary node metastasis in patients with invasive breast cancer[J]. Cancer,1978, 42: 2025.
5Joukov V, Pajusola K, Kaipainen A, et al. A novel Vasculax endothelial growth factor, VEGF-C, is a ligand for the FLT4(VEGFR-3) and KDR(VEGFR-2) receptor tyrosine jinases[J] .EMBO J, 1996,15 (2): 290 - 298.
6Jian-Feng Wang. Ganju RK, Zhong-Ying Liu, et al. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor[J]. Blood, 1997,90(9): 3507 - 3515.
7Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues[J] .FASEB J, 2000, 14( 13): 2087 - 2097.
8Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis[J]. British J Cancer, 1999,80(1/2): 309 - 313.
9Kitadai Y, Amioka T, Haruma K, et al. Clinicopatholagical significance of vascular endothelial growth factor (VEGF) -C in human esophageal squamous cell carcinomas[J] . Int J Cancer,2001, 93(5): 662 - 666.
10Dumont DJ, Jussila L, Taipale J, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor 3[J]. Science, 1998,282 (5390): 946 - 949.
